EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

PRMT6 deficiency or inhibition alleviates neuropathic pain by decreasing glycolysis and inflammation in microglia

Tong Hua, Erliang Kong, Hailing Zhang, Jinfang Lu, Kesheng Huang, Ruifeng Ding, Haowei Wang, Jian Li, Chaofeng Han, Hongbin Yuan

Brain, Behavior, and Immunity · 2024-05 · 118 · 101-114

DOI: 10.1016/j.bbi.2024.02.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2024-05. Verfasst von Tong Hua und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Changzheng Hospital, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Microglia, Neuralgia. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microglia induced chronic inflammation is the critical pathology of Neuropathic pain (NP). Metabolic reprogramming of macrophage has been intensively reported in various chronic inflammation diseases. However, the metabolic reprogramming of microglia in chronic pain remains to be elusive. Here, we reported that immuno-metabolic markers (HIF-1α, PKM2, GLUT1 and lactate) were related with increased expression of PRMT6 in the ipsilateral spinal cord dorsal horn of the chronic construction injury (CCI) mice. PRMT6 deficiency or prophylactic and therapeutic intrathecal administration of PRMT6 inhibitor (EPZ020411) ameliorated CCI-induced NP, inflammation and glycolysis in the ipsilateral spinal cord dorsal horn. PRMT6 knockout or knockdown inhibited LPS-induced inflammation, proliferation and glycolysis in microglia cells. While PRMT6 overexpression exacerbated LPS-induced inflammation, proliferation and glycolysis in BV2 cells. Recent research revealed that PRMT6 could interact with and methylate HIF-1α, which increased HIF-1α protein stability. In sum, increased expression of PRMT6 exacerbates NP progress by increasing glycolysis and neuroinflammation through interacting with and stabilizing HIF-1α in a methyltransferase manner, which outlines novel pathological mechanism and drug target for NP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaNeuralgiaMiceAnimalsLipopolysaccharidesInflammationGlycolysis

Stichwörter der Autor:innen

ImmunometabolismMicrogliaNeuroinflammationNeuropathic painPRMT6

Substanzen

Lipopolysaccharides

Autor:innen und Institutionen

  • Department of Anesthesiology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Department of Anesthesiology, Changzheng Hospital, Naval Medical University, Shanghai, China; Department of Anesthesiology, The No. 988 Hospital of Joint Logistic Support Force of Chinese People's Liberation Army, Zheng…
  • Department of Neurology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Department of Histology and Embryology, and Shanghai Key Laboratory of Cell Engineering, Naval Medical University, Shanghai, China. Electronic address: hcf@immunol.org.
  • Department of Anesthesiology, Changzheng Hospital, Naval Medical University, Shanghai, China. Electronic address: jfjczyy@aliyun.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hua, T., Kong, E., Zhang, H., Lu, J., Huang, K., Ding, R., Wang, H., Li, J., Han, C., & Yuan, H. (2024). PRMT6 deficiency or inhibition alleviates neuropathic pain by decreasing glycolysis and inflammation in microglia. Brain, Behavior, and Immunity, 118, 101-114. https://doi.org/10.1016/j.bbi.2024.02.027

Vancouver

Hua T, Kong E, Zhang H, Lu J, Huang K, Ding R, et al. PRMT6 deficiency or inhibition alleviates neuropathic pain by decreasing glycolysis and inflammation in microglia. Brain, Behavior, and Immunity. 2024;118:101-114. doi:10.1016/j.bbi.2024.02.027

BibTeX
@article{Hua2024,
  author = {Hua, Tong and Kong, Erliang and Zhang, Hailing and Lu, Jinfang and Huang, Kesheng and Ding, Ruifeng and Wang, Haowei and Li, Jian and Han, Chaofeng and Yuan, Hongbin},
  title = {PRMT6 deficiency or inhibition alleviates neuropathic pain by decreasing glycolysis and inflammation in microglia},
  journal = {Brain, Behavior, and Immunity},
  year = {2024},
  volume = {118},
  pages = {101--114},
  doi = {10.1016/j.bbi.2024.02.027}
}
Kostenlos starten →